Currently predicting for Thu, 4 Jun 2026

GERN Prediction Chart

GERN Predictions History

Latest community submissions for GERN.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 6, 2023 $3.80 +4.97% $3.60 X 94.44% 0
May 31, 2023 $3.26 -1.91% $3.27 V 99.59% 5
May 31, 2023 $3.28 -1.19% $3.27 V 99.68% 5
May 31, 2023 Bullish $3.27 X 0
Feb 17, 2023 $2.79 +2.53% $2.81 V 99.25% 3
Feb 17, 2023 $2.76 +1.58% $2.81 V 98.33% 1
Feb 17, 2023 Bearish $2.81 X 0
Feb 1, 2023 $3.39 +2.62% $3.38 V 99.81% 6
Feb 1, 2023 $3.35 +1.64% $3.38 V 99.23% 3
Feb 1, 2023 Bullish $3.38 V 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for GERN with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT GERON CORPORATION
Geron
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes a...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE